Emerging molecular targeted therapies in the treatment of head and neck cancer
Bozec, Alexandre, Peyrade, Frédéric, Fischel, Jean-Louis, Milano, Gérard
Published in Expert opinion on emerging drugs (01.06.2009)
Published in Expert opinion on emerging drugs (01.06.2009)
Get more information
Journal Article
Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants
Chefrour, Mohamed, Milano, Gérard, Formento, Patricia, Giacometti, Sarah, Denden, Amine, Renée, Nicole, Iliadis, Athanassios, Fischel, Jean-Louis, Ciccolini, Joseph
Published in Fundamental & clinical pharmacology (01.08.2012)
Published in Fundamental & clinical pharmacology (01.08.2012)
Get full text
Journal Article
Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line
Monteverde, Martino, Ph.D, Tonissi, Federica, Ph.D, Fischel, Jean-Louis, Ph.D, Etienne-Grimaldi, Marie-Christine, Ph.D, Milano, Gerard, Ph.D, Merlano, Marco, M.D, Lo Nigro, Cristiana, Ph.D
Published in Urologic oncology (01.08.2013)
Published in Urologic oncology (01.08.2013)
Get full text
Journal Article
Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines
Guérin, Olivier, M.D, Etienne-Grimaldi, Marie-Christine, Ph.D, Monteverde, Martino, Ph.D, Sudaka, Anne, Ph.D, Brunstein, Marie-Christine, Formento, Patricia, Lattanzio, Laura, Ph.D, Maffi, Monica, Ph.D, Tonissi, Federica, Ph.D, Ortholan, Cécile, M.D, Pagès, Gilles, Ph.D, Fischel, Jean-Louis, Ph.D, Lo Nigro, Cristiana, Ph.D, Merlano, Marco, M.D, Milano, Gérard, Ph.D
Published in Urologic oncology (01.11.2013)
Published in Urologic oncology (01.11.2013)
Get full text
Journal Article
Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation
Bozec, Alexandre, Formento, Patricia, Ciccolini, Joseph, Fanciullino, Raphaëlle, Padovani, Laetitia, Murraciole, Xavier, Fischel, Jean-Louis, Milano, Gerard
Published in Molecular cancer therapeutics (01.12.2005)
Published in Molecular cancer therapeutics (01.12.2005)
Get full text
Journal Article
The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab–bevacizumab–irradiation combination on head and neck cancer xenografts
Bozec, Alexandre, Etienne-Grimaldi, Marie-Christine, Fischel, Jean-Louis, Sudaka, Anne, Toussan, Nicolas, Formento, Patricia, Milano, Gérard
Published in Oral oncology (01.05.2011)
Published in Oral oncology (01.05.2011)
Get full text
Journal Article
Activation of nuclear factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: A brake to apoptosis in HeLa human carcinoma cells
BOTTERO, Virginie, BUSUTTIL, Valère, LOUBAT, Agnès, MAGNE, Nicolas, FISCHEL, Jean-Louis, MILANO, Gérard, PEYRON, Jean-Francois
Published in Cancer research (Chicago, Ill.) (01.11.2001)
Get full text
Published in Cancer research (Chicago, Ill.) (01.11.2001)
Journal Article
Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study
Sudaka, Anne, Susini, Antoine, Lo Nigro, Cristiana, Fischel, Jean-Louis, Toussan, Nicolas, Formento, Patricia, Tonissi, Federica, Lattanzio, Laura, Russi, Elvio, Etienne-Grimaldi, Marie-Christine, Merlano, Marco, Milano, Gérard
Published in Investigational new drugs (01.02.2013)
Published in Investigational new drugs (01.02.2013)
Get full text
Journal Article
Antitumor activity of cetuximab associated with the taxotere–cisplatin–fluorouracil (TPF) combination on an orthotopic head and neck cancer model
Bozec, Alexandre, Sudaka, Anne, Etienne-Grimaldi, Marie-Christine, Brunstein, Marie-Christine, Fischel, Jean-Louis, Milano, Gérard
Published in Oral oncology (01.10.2011)
Published in Oral oncology (01.10.2011)
Get full text
Journal Article
Epidermal growth factor receptor/angiogenesis dual targeting: preclinical experience
Bozec, Alexandre, Fischel, Jean-Louis, Milano, Gerard
Published in Current opinion in oncology (01.07.2006)
Published in Current opinion in oncology (01.07.2006)
Get more information
Journal Article
EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment
Guérin, Olivier, Fischel, Jean Louis, Ferrero, Jean-Marc, Bozec, Alexandre, Milano, Gerard
Published in Pharmaceuticals (19.07.2010)
Published in Pharmaceuticals (19.07.2010)
Get full text
Journal Article
Book Review
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition
Bozec, Alexandre, Gros, François-Xavier, Penault-Llorca, Frédérique, Formento, Patricia, Cayre, Anne, Dental, Clélia, Etienne-Grimaldi, Marie-Christine, Fischel, Jean-Louis, Milano, Gérard
Published in European journal of cancer (1990) (01.09.2008)
Published in European journal of cancer (1990) (01.09.2008)
Get full text
Journal Article
Tapered dose versus constant drug exposure to anti-EGFR drugs on head-and-neck cancer xenografts. A comparison between cetuximab and gefitinib
Bozec, Alexandre, Formento, Patricia, Fischel, Jean-Louis, Etienne-Grimaldi, Marie-Christine, Milano, Gérard
Published in Oral oncology (01.03.2010)
Published in Oral oncology (01.03.2010)
Get full text
Journal Article
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: Rational basis for a new combination therapy with capecitabine
MAGNE, Nicolas, FISCHEL, Jean-Louis, MILANO, Gérard, DUBREUIL, Alain, FORMENTO, Patricia, CICCOLINI, Joseph, FORMENTO, Jean-Louis, TIFFON, Céline, RENEE, Nicole, MARCHETTI, Sandrine, ETIENNE, Marie-Christine
Published in Clinical cancer research (15.10.2003)
Get full text
Published in Clinical cancer research (15.10.2003)
Journal Article
Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression
Fantozzi, Ivana, Grall, Dominique, Cagnol, Sébastien, Stanchi, Fabio, Sudaka, Anne, Brunstein, Marie-Christine, Bozec, Alexandre, Fischel, Jean-Louis, Milano, Gerard, Van Obberghen-Schilling, Ellen
Published in Acta oncologica (01.01.2008)
Published in Acta oncologica (01.01.2008)
Get full text
Journal Article
Gefitinib–trastuzumab combination on hormone-refractory prostate cancer xenograft
Formento, Patricia, Hannoun-Levi, Jean-Michel, Gérard, Françoise, Mazeau, Christiane, Fischel, Jean-Louis, Etienne-Grimaldi, M.C., Gugenheim, Jean, Milano, Gérard
Published in European journal of cancer (1990) (01.07.2005)
Published in European journal of cancer (1990) (01.07.2005)
Get full text
Journal Article
Dual HER 1-2 targeting of hormone-refractory prostate cancer by ZD1839 and trastuzumab
Formento, Patricia, Hannoun-Levi, Jean-Michel, Fischel, Jean-Louis, Magné, Nicolas, Etienne-Grimaldi, Marie-Christine, Milano, Gérard
Published in European journal of cancer (1990) (01.12.2004)
Published in European journal of cancer (1990) (01.12.2004)
Get full text
Journal Article
Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridine
Fischel, Jean-Louis, Ciccolini, Joseph, Formento, Patricia, Ferrero, Jean-Marc, Milano, Gérard
Published in Anti-cancer drugs (01.08.2006)
Published in Anti-cancer drugs (01.08.2006)
Get more information
Journal Article
Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes
Fischel, Jean-Louis, Formento, Patricia, Ciccolini, Joseph, Etienne-Grimaldi, Marie-Christine, Milano, G
Published in Anti-cancer drugs (01.11.2004)
Published in Anti-cancer drugs (01.11.2004)
Get more information
Journal Article
Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells
Fischel, Jean-Louis, Ferrero, Jean-Marc, Formento, Patricia, Ciccolini, Joseph, Renée, Nicole, Formento, Jean-Louis, Milano, G
Published in Anti-cancer drugs (01.03.2005)
Published in Anti-cancer drugs (01.03.2005)
Get more information
Journal Article